Lv11
30 积分 2024-10-15 加入
[Immune checkpoint inhibitors induced pituitary immune-related adverse events: diagnosis and management]
1小时前
已完结
Retrospective Analysis of the Safety and Efficacy of Interleukin-2 After Prior VEGF-targeted Therapy in Patients With Advanced Renal Cell Carcinoma
14天前
已完结
Efficacy and safety of immune checkpoint inhibitors combined with anti-VEGF therapy in the treatment of unresectable or advanced liver cancer: a systematic review
16天前
已完结
皖公网安备34019202002308
